Skip to main content
Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
20.65
+0.18 (0.88%)
Nov 22, 2024, 4:00 PM EST - Market closed

Genmab Revenue

Genmab had revenue of 5.54B DKK in the quarter ending September 30, 2024, with 17.57% growth. This brings the company's revenue in the last twelve months to 19.84B, up 17.75% year-over-year. In the year 2023, Genmab had annual revenue of 16.47B with 13.57% growth.

Revenue (ttm)
19.84B DKK
Revenue Growth
+17.75%
P/S Ratio
n/a
Revenue / Employee
9,003,630 DKK
Employees
2,204
Market Cap
13.13B USD

Revenue Chart

* This company reports financials in DKK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202316.47B1.97B13.57%
Dec 31, 202214.51B6.09B72.33%
Dec 31, 20218.42B-1.69B-16.75%
Dec 31, 202010.11B4.75B88.43%
Dec 31, 20195.37B2.34B77.39%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fresenius Medical Care AG 21.46B
Universal Health Services 15.42B
DaVita 12.67B
Solventum 8.22B
Incyte 4.08B
Dr. Reddy's Laboratories 3.58B
BioMarin Pharmaceutical 2.75B
Revvity 2.72B
Revenue Rankings

GMAB News

More News